HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Beom Park Selected Research

Rituximab (Mabthera)

1/2023Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center.
8/2021Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis.
1/2012Multicenter retrospective analysis of the effectiveness and safety of rituximab in korean patients with refractory systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Beom Park Research Topics

Disease

92Vasculitis (Vasculitides)
02/2024 - 03/2017
64Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2024 - 03/2017
49Rheumatoid Arthritis
01/2023 - 08/2002
18Microscopic Polyangiitis
03/2024 - 03/2017
17Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
12/2023 - 11/2012
17Chronic Kidney Failure (Chronic Renal Failure)
10/2023 - 03/2018
14Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 07/2010
14Inflammation (Inflammations)
01/2022 - 12/2012
13Autoimmune Diseases (Autoimmune Disease)
11/2023 - 02/2012
13Infections
01/2023 - 10/2006
11Pain (Aches)
07/2023 - 07/2014
10Knee Osteoarthritis
07/2023 - 04/2016
10Ankylosing Spondylitis
10/2021 - 04/2007
8Interstitial Lung Diseases (Interstitial Lung Disease)
10/2023 - 07/2020
7Churg-Strauss Syndrome (Allergic Angiitis)
09/2023 - 08/2018
6Diabetes Mellitus
10/2023 - 09/2017
6Arthritis (Polyarthritis)
04/2022 - 03/2009
5Systemic Scleroderma (Systemic Sclerosis)
01/2024 - 09/2017
5Dermatomyositis (Dermatopolymyositis)
10/2023 - 07/2010
5Stroke (Strokes)
01/2023 - 08/2020
5Proteinuria
07/2020 - 12/2012
5Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 10/2012
5Experimental Arthritis
01/2020 - 03/2009
5Neoplasms (Cancer)
11/2019 - 08/2006
4Liver Diseases (Liver Disease)
02/2024 - 10/2012
4Fibrosis (Cirrhosis)
01/2023 - 03/2019
4Tuberculosis (Tuberculoses)
11/2022 - 05/2012
4Fever (Fevers)
04/2022 - 01/2017
4Lupus Nephritis
07/2020 - 07/2013
4Nephritis
11/2019 - 12/2012
4Osteoarthritis
10/2019 - 04/2016
3Polymyositis
10/2023 - 04/2022
3Glomerulonephritis
01/2023 - 07/2020
3Granuloma
01/2023 - 01/2019
3Latent Tuberculosis
11/2022 - 03/2014
3Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2022 - 12/2021
3Takayasu Arteritis (Arteritis, Takayasu's)
10/2020 - 07/2010
3Immunoglobulin G4-Related Disease
10/2020 - 08/2017
3Chronic Disease (Chronic Diseases)
08/2020 - 01/2009
2Non-alcoholic Fatty Liver Disease
02/2024 - 01/2023
2Sarcopenia
09/2023 - 06/2022
2Type 2 Diabetes Mellitus (MODY)
08/2023 - 05/2022
2Disease Progression
08/2023 - 12/2020
2Acute Coronary Syndrome
04/2023 - 06/2022

Drug/Important Bio-Agent (IBA)

113Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
03/2024 - 03/2017
16Biomarkers (Surrogate Marker)IBA
01/2023 - 09/2014
13Methotrexate (Mexate)FDA LinkGeneric
01/2023 - 02/2012
12C-Reactive ProteinIBA
12/2023 - 04/2007
12CytokinesIBA
10/2023 - 03/2009
9Peroxidase (Myeloperoxidase)IBA
03/2024 - 03/2017
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2009
8Myeloblastin (Proteinase 3)IBA
03/2024 - 03/2017
8Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2023 - 01/2009
8CreatinineIBA
10/2023 - 01/2020
8AlbuminsIBA
01/2023 - 01/2017
8Tumor Necrosis Factor InhibitorsIBA
08/2022 - 03/2014
7Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2017
6Therapeutic UsesIBA
11/2023 - 03/2009
6Alanine Transaminase (SGPT)IBA
10/2023 - 01/2009
6Serum AlbuminIBA
03/2022 - 07/2016
6Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2014
6Biosimilar PharmaceuticalsIBA
01/2021 - 01/2017
5Antirheumatic Agents (DMARD)IBA
10/2021 - 08/2002
4GlucocorticoidsIBA
12/2021 - 09/2012
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2021 - 03/2013
4Azathioprine (Imuran)FDA LinkGeneric
08/2021 - 03/2013
4Immunoglobulin G (IgG)IBA
04/2021 - 08/2017
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2021 - 03/2013
4Ferritins (Ferritin)IBA
11/2018 - 01/2009
3InterleukinsIBA
10/2023 - 01/2011
3NitrogenIBA
10/2023 - 01/2022
3Urea (Carbamide)FDA LinkGeneric
10/2023 - 01/2022
3Hyaluronic Acid (Hyaluronan)IBA
07/2023 - 01/2017
3Rituximab (Mabthera)FDA Link
01/2023 - 01/2012
3Anti-Citrullinated Protein AntibodiesIBA
11/2022 - 07/2012
3Antiphospholipid AntibodiesIBA
11/2022 - 07/2019
3Rheumatoid FactorIBA
11/2022 - 01/2017
3AutoantibodiesIBA
10/2022 - 03/2021
3Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2022 - 04/2007
3insulin receptor-related receptor (IRR)IBA
01/2022 - 05/2019
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2011
3AdipokinesIBA
01/2021 - 01/2013
3Etanercept (Enbrel)FDA Link
01/2021 - 01/2017
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2020 - 08/2002
3Infliximab (Remicade)FDA Link
08/2020 - 02/2020
3CT-P13IBA
08/2020 - 02/2020
3Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2019 - 07/2018
3Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2018 - 11/2009
3CollagenIBA
01/2018 - 10/2006
3Celecoxib (Celebrex)FDA Link
08/2016 - 01/2014
3Liver X ReceptorsIBA
05/2014 - 05/2010
2Interleukin-27 (Interleukin 27)IBA
10/2023 - 01/2021
2GlobulinsIBA
06/2023 - 02/2019
2Carbon MonoxideIBA
01/2023 - 09/2017

Therapy/Procedure

23Therapeutics
02/2022 - 08/2002
7Knee Replacement Arthroplasty (Total Knee Replacement)
06/2022 - 05/2014
4Injections
07/2023 - 01/2017
4Aftercare (After-Treatment)
01/2022 - 08/2017
3Intra-Articular Injections
07/2023 - 07/2019
2Osteotomy
01/2023 - 01/2022